Initiator Pharma A/S Cash Flow-to-Debt Ratio
Initiator Pharma A/S cash flow-to-debt ratio. Initiator Pharma A/S (INIT) has a Cash Flow-to-Debt Ratio of -1.07x as of September 2025, meaning its operating cash flow of Skr-4.68 Million could theoretically repay -1% of its total liabilities (Skr4.37 Million) in one year. Check INIT cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Initiator Pharma A/S (2016–2024)
Cash flow-to-debt ratio of Initiator Pharma A/S from 2016 to 2024. Historical debt coverage capacity for Initiator Pharma A/S across 9 annual periods. Check INIT total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Initiator Pharma A/S Cash Flow-to-Debt Ratio by Year (2016–2024)
Initiator Pharma A/S cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Initiator Pharma A/S. For the full cash flow conversion analysis, see INIT operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -23.69x | Skr-12.08 Million | Skr510.00K | ▼ -2399.8% |
| 2023 | -0.95x | Skr-17.65 Million | Skr18.62 Million | ▲ +58.5% |
| 2022 | -2.28x | Skr-32.70 Million | Skr14.32 Million | ▼ -25.3% |
| 2021 | -1.82x | Skr-34.10 Million | Skr18.71 Million | ▲ +73.0% |
| 2020 | -6.75x | Skr-8.06 Million | Skr1.19 Million | ▼ -20.8% |
| 2019 | -5.59x | Skr-8.55 Million | Skr1.53 Million | ▲ +68.8% |
| 2018 | -17.92x | Skr-13.58 Million | Skr758.00K | ▼ -667.5% |
| 2017 | -2.33x | Skr-7.78 Million | Skr3.33 Million | ▼ -1125.1% |
| 2016 | -0.19x | Skr-178.00K | Skr934.00K | — |